Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health In Tech (HIT) Shares Outstanding (Weighted Average) (2023 - 2025)

Health In Tech has reported Shares Outstanding (Weighted Average) over the past 3 years, most recently at $55.8 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $55.8 million for Q4 2025, up 7.72% from a year ago — trailing twelve months through Dec 2025 was $55.8 million (up 7.72% YoY), and the annual figure for FY2025 was $55.8 million, up 7.72%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $55.8 million at Health In Tech, down from $56.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for HIT hit a ceiling of $56.4 million in Q3 2025 and a floor of $47.8 million in Q4 2023.
  • Median Shares Outstanding (Weighted Average) over the past 3 years was $51.8 million (2024), compared with a mean of $53.0 million.
  • Peak annual rise in Shares Outstanding (Weighted Average) hit 9.01% in 2025, while the deepest fall reached 5.51% in 2025.
  • Health In Tech's Shares Outstanding (Weighted Average) stood at $47.8 million in 2023, then rose by 8.37% to $51.8 million in 2024, then rose by 7.72% to $55.8 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $55.8 million (Q4 2025), $56.4 million (Q3 2025), and $55.4 million (Q2 2025) per Business Quant data.